Willow Grove, PA, Jan. 03, 2017 -- Azzur Group, LLC, a private equity firm with holdings in the life sciences consulting industry, is pleased to announce the acquisition of US-based training company, Learnaboutgmp.
Learnaboutgmp is an online training and education platform for biotechnology, pharmaceutical, and medical device companies. This platform has allowed some of the top international pharmaceutical companies to greatly increase their compliance knowledge and compliment their existing in-house training. The acquisition will allow Azzur Group to offer clients and competitors alike convenient and actionable training.
“We believe Learnaboutgmp is the resource that many companies have been looking for to add strength to their current team members and to allow members to grow in their career in the life science field,” said Thomas O’Donnell, Managing Partner of Azzur Group. "We are excited for the opportunities this new partnership will bring to our existing client base, and for the strength it will bring our incoming clients to bridge this talent gap.”
Visit Learnaboutgmp.com to find out more, and to sign up for a free 14 day trial and demo.
About Azzur Group, LLC- Azzur Group is a private equity firm comprised of a network of high-level life science companies, created to provide efficient and cost-effective solutions. As one of the fastest-growing, private companies in America, Azzur is firmly focused on providing seamless service to our customers. Our team of experienced industry professionals serves the pharmaceutical, biotechnology, and medical device industry by providing one-stop access to a wide-range of project management, process engineering, and compliance services within the life science industry.
About Learnaboutgmp- Learnaboutgmp is a cloud-based learning management system (LMS) designed specifically for life science and regulatory organizations. Our LMS contains the courses you need to help you achieve regulatory compliance. With new courses published every month and existing courses updated in line with regulatory changes, we are your true continuous learning platform.
“Learnaboutgmp’s content is developed by leading subject experts resulting in courses that are current, relevant and meaningful to learners. Every course was given a huge thumbs up by our internal Quality Systems leaders. Hands down, working with Learnaboutgmp has been one of the best engagements we have had in over 18 years of managing vendor course content and relationships. I highly recommend them to any Pharma organization interested in deploying top notch GMP related courseware.”
- VP, Global Quality Learning Top 5 Pharma Company
Graham O’Keeffe CEO [email protected] 4315 Independence Drive Schnecksville, PA, 18078 USA 315.636.4782


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



